Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Joseph V Pergolizzi$suffix/text()$suffix/text(), Peter Magnusson, Jo Ann LeQuang, Frank Breve, Kailyn Mitchell, Maninder Chopra & Giustino Varrassi. (2021) Transdermal Buprenorphine for Acute Pain in the Clinical Setting: A Narrative Review. Journal of Pain Research 14, pages 871-879.
Read now
Read now
Jin Seok Ahn, Johnson Lin, Setsuro Ogawa, Chen Yuan, Tony O’Brien, Brian HC Le, Andrea M Bothwell, Hanlim Moon, Yacine Hadjiat & Abhijith Ganapathi. (2017) Transdermal buprenorphine and fentanyl patches in cancer pain: a network systematic review. Journal of Pain Research 10, pages 1963-1972.
Read now
Read now
Krzysztof Nosek, Wojciech Leppert, Hanna Nosek, Jerzy Wordliczek & Dariusz Onichimowski. (2017) A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients. Drug Design, Development and Therapy 11, pages 2409-2419.
Read now
Read now
Johan Menten, Isabelle Carpentier, Harlinde Deschutter, Sandra Nuyts & Karen Van Beek. (2013) The Use of Transdermal Buprenorphine to Relieve Radiotherapy-Related Pain in Head and Neck Cancer Patients. Cancer Investigation 31:6, pages 412-420.
Read now
Read now
PMJ Clement, B Beuselinck, PG Mertens, P Cornelissen & J Menten. (2013) PAIN MANAGEMENT IN PALLIATIVE CANCER PATIENTS: A PROSPECTIVE OBSERVATIONAL STUDY ON THE USE OF HIGH DOSAGES OF TRANSDERMAL BUPRENORPHINE. Acta Clinica Belgica 68:2, pages 87-91.
Read now
Read now
Anna Przeklasa-Muszynska & Jan Dobrogowski. (2011) Transdermal buprenorphine for the treatment of moderate to severe chronic pain: results from a large multicenter, non-interventional post-marketing study in Poland. Current Medical Research and Opinion 27:6, pages 1109-1117.
Read now
Read now
Pasquale Niscola, Laura Scaramucci, Claudio Romani, Marco Giovannini, Andrea Tendas, Gregorio Brunetti, Claudio Cartoni, Roberto Palumbo, Gisella Vischini, Agostina Siniscalchi, Paolo de Fabritiis & Tommaso Caravita. (2010) Pain management in multiple myeloma. Expert Review of Anticancer Therapy 10:3, pages 415-425.
Read now
Read now
Guy Hans & Dominique Robert. (2009) Transdermal buprenorphine – a critical appraisal of its role in pain management. Journal of Pain Research 2, pages 117-134.
Read now
Read now
Articles from other publishers (40)
Ke Ma, Wei Jiang, Yun-Xia Wang, Lin Wang, Yan Lv, Jin-Feng Liu, Rong-Guo Liu, Hui Liu, Li-Zu Xiao, Dong-Ping Du, Li-Juan Lu, Xiao-Qiu Yang, Ling-Jie Xia, Dong Huang, Zhi-Jian Fu, Bao-Gan Peng & Yan-Qing Liu. (2021) Expert consensus of the Chinese Association for the Study of Pain on pain treatment with the transdermal patch. World Journal of Clinical Cases 9:9, pages 2110-2122.
Crossref
Crossref
Maksim Khotimchenko, Victor Antontsev, Kaushik Chakravarty, Hypatia Hou & Jyotika Varshney. (2021) In Silico Simulation of the Systemic Drug Exposure Following the Topical Application of Opioid Analgesics in Patients with Cutaneous Lesions. Pharmaceutics 13:2, pages 284.
Crossref
Crossref
Christy Anthony, Armen Haroutunian, Eric Hsu, James Ashford, Rene Przkora, Teresa Ojode & Andrea Trescot. 2021. Fundamentals of Cancer Pain Management. Fundamentals of Cancer Pain Management
107
124
.
Robert A. SwarmJudith A. PaiceDoralina L. AnghelescuMadhuri AreJustine Yang BruceSorin BugaMarcin ChwistekCharles CleelandDavid CraigEllin GaffordHeather GreenleeEric HansenArif H. KamalMihir M. KamdarSusan LeGrandSean MackeyM. Rachel McDowellNatalie MorylLisle M. NabellSuzanne Nesbit, Nina O’ConnorMichael W. RabowElizabeth RickersonRebecca ShatskyJill SindtSusan G. UrbaJeanie M. Youngwerth, Lydia J. Hammond & Lisa A. Gurski. (2019) Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network 17:8, pages 977-1007.
Crossref
Crossref
Aurora Naa-Afoley Quaye & Yi Zhang. (2019) Perioperative Management of Buprenorphine: Solving the Conundrum. Pain Medicine 20:7, pages 1395-1408.
Crossref
Crossref
Daniel Humberto Pozza, Sara Gil-Mata, Andreia Fontoura Oliveira, Alice Turner, Ramon Andrade De Mello & Newton Barros. 2019. International Manual of Oncology Practice. International Manual of Oncology Practice
1071
1113
.
Wojciech Leppert, Malgorzata Malec–Milewska, Renata Zajaczkowska & Jerzy Wordliczek. (2018) Transdermal and Topical Drug Administration in the Treatment of Pain. Molecules 23:3, pages 681.
Crossref
Crossref
. (2017) Treat chronic pain with appropriate non-oral formulations of opioids in patients who have difficulty swallowing. Drugs & Therapy Perspectives 33:12, pages 566-570.
Crossref
Crossref
Jeannine Brant, Lisa Keller, Karen McLeod, Chao Hsing Yeh & Linda Eaton. (2017) Chronic and Refractory Pain: A Systematic Review of Pharmacologic Management in Oncology
. Clinical Journal of Oncology Nursing 21:3, pages 31-59.
Crossref
Crossref
K. Ma, P. Ma, H. Lu, S. Liu & Q. Cao. (2017)
Fentanyl Suppresses the Survival of CD4
+
T Cells Isolated from Human Umbilical Cord Blood through Inhibition of IKKs-mediated NF-
κ
B Activation
. Scandinavian Journal of Immunology 85:5, pages 343-349.
Crossref
Crossref
Sebastiano Mercadante. (2017) Options for Treating Pain in Cancer Patients with Dysphagia. Drugs 77:6, pages 629-635.
Crossref
Crossref
Weiyang Christopher Liu, Zhong Xi Zheng, Kian Hian Tan & Gregory J. Meredith. (2017) Multidimensional Treatment of Cancer Pain. Current Oncology Reports 19:2.
Crossref
Crossref
Eric Prommer. (2014) Buprenorphine for Cancer Pain. American Journal of Hospice and Palliative Medicine® 32:8, pages 881-889.
Crossref
Crossref
Joseph V. Pergolizzi, Christopher Gharibo & Kok-Yuen Ho. (2015) Treatment Considerations for Cancer Pain: A Global Perspective. Pain Practice 15:8, pages 778-792.
Crossref
Crossref
Joseph V. PergolizziJr.Jr., Robert TaylorJr.Jr. & Robert B. Raffa. (2015) The Potential Role of an Extended-Release, Abuse-Deterrent Oxycodone/Acetaminophen Fixed-Dose Combination Product for the Treatment of Acute Pain. Advances in Therapy 32:6, pages 485-495.
Crossref
Crossref
B. Afsharimani, K. Kindl, P. Good & J. Hardy. (2015) Pharmacological options for the management of refractory cancer pain—what is the evidence?. Supportive Care in Cancer 23:5, pages 1473-1481.
Crossref
Crossref
Daniel Humberto Pozza, Sara Gil-Mata, Andreia Fontoura Oliveira, Alice Turner, Ramon Andrade de Mello & Newton Barros. 2015. International Manual of Oncology Practice. International Manual of Oncology Practice
829
866
.
Joseph V. Pergolizzi Jr, Robert Taylor Jr, Gianpietro Zampogna, Fuat H. Demirelli, Serdar Erdine & Robert B. Raffa. (2014) Oxycodone Immediate Release for Cancer Pain Management in Turkey: Maximizing Value in Opioid Analgesics. Journal of Cancer Research Updates 3:4.
Crossref
Crossref
Georg Bollig & Andreas Gremmelt. (2014) Possible anaphylactic reaction to transdermal buprenorphine: a case report. Research 1.
Crossref
Crossref
Wojciech Leppert. (2013) A successful Switch From Transdermal Fentanyl to Transdermal Buprenorphine in a Patient with Neuropathic Pain. American Journal of Hospice and Palliative Medicine® 31:1, pages 101-104.
Crossref
Crossref
Julie W. Childers & Robert M. Arnold. (2013) Low-Dose Buprenorphine Patch for Pain #268. Journal of Palliative Medicine 16:10, pages 1299-1300.
Crossref
Crossref
Mary Beth Babos, Brittany Grady, Warren Wisnoff & Christy McGhee. (2013) Pathophysiology of pain. Disease-a-Month 59:10, pages 330-358.
Crossref
Crossref
Wojciech LeppertGrzegorz Kowalski. (2018) Methadone as An Additional Opioid for A Cancer Patient with Severe Neuropathic and Bone Pain Not Responsive to Other Opioids and Adjuvant Analgesics. Journal of Palliative Care 29:2, pages 119-121.
Crossref
Crossref
Cho-Min Naing, Kyan Aung & Peng Nam Yeoh. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Lino Becerra, Jaymin Upadhyay, Pei-Ching Chang, James Bishop, Julie Anderson, Richard Baumgartner, Adam J. Schwarz, Alexandre Coimbra, Diana Wallin, Lauren Nutile, Edward George, Gary Maier, Soujanya Sunkaraneni, Smriti Iyengar, Jeffrey L. Evelhoch, David Bleakman, Richard Hargreaves & David Borsook. (2013) Parallel Buprenorphine phMRI Responses in Conscious Rodents and Healthy Human Subjects. Journal of Pharmacology and Experimental Therapeutics 345:1, pages 41-51.
Crossref
Crossref
Tracy P. Jackson, Daniel F. Lonergan, R. David Todd & Peter R. Martin. (2012) Intentional Intrathecal Opioid Detoxification in 3 Patients: Characterization of the Intrathecal Opioid Withdrawal Syndrome. Pain Practice 13:4, pages 297-309.
Crossref
Crossref
Stephen M. Husbands. 2013. Research and Development of Opioid-Related Ligands. Research and Development of Opioid-Related Ligands
127
144
.
Lisa Koodie & Sabita Roy. 2013. Morphine and Metastasis. Morphine and Metastasis
31
46
.
Shalini Dalal & Eduardo Bruera. 2013. Handbook of Methadone Prescribing and Buprenorphine Therapy. Handbook of Methadone Prescribing and Buprenorphine Therapy
241
261
.
Guy Hans. 2013. Handbook of Methadone Prescribing and Buprenorphine Therapy. Handbook of Methadone Prescribing and Buprenorphine Therapy
109
137
.
Paul Sloan. (2012) Buprenorphine for Chronic Pain Management. The Journal of Supportive Oncology 10:6, pages 220-221.
Crossref
Crossref
Mellar P. Davis. (2012) Twelve Reasons for Considering Buprenorphine as a Frontline Analgesic in the Management of Pain. The Journal of Supportive Oncology 10:6, pages 209-219.
Crossref
Crossref
Robert F WolffKim Reid, Marcello di Nisio, Dagfinn Aune, Carla Truyers, Adrian V Hernandez, Kate Misso, Rob Riemsma & Jos Kleijnen. (2012) Systematic review of adverse events of buprenorphine patch versus fentanyl patch in patients with chronic moderate-to-severe pain. Pain Management 2:4, pages 351-362.
Crossref
Crossref
Jaymin Upadhyay, Julie Anderson, Richard Baumgartner, Alexandre Coimbra, Adam J. Schwarz, Gautam Pendse, Diana Wallin, Lauren Nutile, James Bishop, Edward George, Igor Elman, Soujanya Sunkaraneni, Gary Maier, Smriti Iyengar, Jeffrey L. Evelhoch, David Bleakman, Richard Hargreaves, Lino Becerra & David Borsook. (2012) Modulation of CNS pain circuitry by intravenous and sublingual doses of buprenorphine. NeuroImage 59:4, pages 3762-3773.
Crossref
Crossref
Cho-Min Naing, Kyan Aung & Peng Nam Yeoh. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Cristiana Guetti, Chiara Angeletti, Franco Marinangeli, Alessandra Ciccozzi, Giada Baldascino, Antonella Paladini & Giustino Varrassi. (2010) Transdermal Buprenorphine for Central Neuropathic Pain: Clinical Reports. Pain Practice 11:5, pages 446-452.
Crossref
Crossref
Anna Przeklasa-Muszyńska & Jan Dobrogowski. (2011) Transdermal buprenorphine in the treatment of cancer and non-cancer pain – the results of multicenter studies in Poland. Pharmacological Reports 63:4, pages 935-948.
Crossref
Crossref
Judith A. Paice & Betty Ferrell. (2011) The management of cancer pain. CA: A Cancer Journal for Clinicians 61:3, pages 157-182.
Crossref
Crossref
Carol A. Paronis & Jack Bergman. (2011) Buprenorphine and Opioid Antagonism, Tolerance, and Naltrexone-Precipitated Withdrawal. Journal of Pharmacology and Experimental Therapeutics 336:2, pages 488-495.
Crossref
Crossref
. (2010) Current World Literature. Current Opinion in Supportive & Palliative Care 4:1, pages 46-51.
Crossref
Crossref